Voyager Therapeutics (VYGR) Asset Utilization Ratio (2015 - 2026)
Voyager Therapeutics (VYGR) reported Asset Utilization Ratio of 0.15 for Q1 2026, down 13.69% on a YoY basis from 0.18 in Q1 2025, and up 3.62% sequentially from 0.15 in Q4 2025.
Voyager Therapeutics (VYGR) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of Asset Utilization Ratio data on file, last reported at 0.15 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 13.69% year-over-year to 0.15; the trailing twelve-month figure through Mar 2026 stood at 0.15 (down 13.69% YoY), and the FY2025 full-year result was 0.13, down 41.79% from the prior year.
- Asset Utilization Ratio grew to 0.15 in Q1 2026, from 0.15 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q4 2023 to a low of 0.1 in Q3 2025.
- A 5-year average of 0.32 and a median of 0.24 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio slumped 76.37% in 2022 and jumped 409.54% in 2023, its largest moves.
- Tracing VYGR's Asset Utilization Ratio over 5 years: stood at 0.24 in 2022, then soared by 223.56% to 0.77 in 2023, then plunged by 74.77% to 0.2 in 2024, then declined by 23.47% to 0.15 in 2025, then rose by 3.62% to 0.15 in 2026.
- Business Quant data shows VYGR's Asset Utilization Ratio at 0.15 in Q1 2026, 0.15 in Q4 2025, and 0.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.18 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.52 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.77 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.08 |
| Jun 30, 2021 | 0.59 |